<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">fcmedicine</journal-id><journal-title-group><journal-title xml:lang="ru">Фундаментальная и клиническая медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Fundamental and Clinical Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2500-0764</issn><issn pub-type="epub">2542-0941</issn><publisher><publisher-name>КемГМУ</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">fcmedicine-135</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>КЛИНИЧЕСКИЙ СЛУЧАЙ АКУШЕРСКОГО АТИПИЧНОГО ГЕМОЛИТИКО-УРЕМИЧЕСКОГО СИНДРОМА</article-title><trans-title-group xml:lang="en"><trans-title>CLINICAL CASE OF OBSTETRIC ATYPICAL HEMOLYTIC UREMIC SYNDROME</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кара-Сал</surname><given-names>С. Ч.</given-names></name><name name-style="western" xml:lang="en"><surname>Kara-Sal</surname><given-names>SVETLANA CH.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мозес</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Mozes</surname><given-names>VADIM G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мозес</surname><given-names>К. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Mozes</surname><given-names>KIRA B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рудаева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rudaeva</surname><given-names>ELENA V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захаров</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharov</surname><given-names>IGOR S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елгина</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Yelgina</surname><given-names>SVETLANA I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ РТ «Перинатальный центр Республики Тыва»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tyva Republic Perinatal Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО Кемеровский государственный медицинский университет Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kemerovo State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2019</year></pub-date><volume>4</volume><issue>1</issue><fpage>91</fpage><lpage>99</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кара-Сал С.Ч., Мозес В.Г., Мозес К.Б., Рудаева Е.В., Захаров И.С., Елгина С.И., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Кара-Сал С.Ч., Мозес В.Г., Мозес К.Б., Рудаева Е.В., Захаров И.С., Елгина С.И.</copyright-holder><copyright-holder xml:lang="en">Kara-Sal S.C., Mozes V.G., Mozes K.B., Rudaeva E.V., Zakharov I.S., Yelgina S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://fcm.kemsmu.ru/jour/article/view/135">https://fcm.kemsmu.ru/jour/article/view/135</self-uri><abstract><p>Представлен клинический случай атипичного гемолитико-уремического синдрома в акушерской практике. Атипичный гемолитико-уремический синдром (аГУС) - орфанное заболевание, сопровождается крайне высокой летальностью, достигающей при своевременно установленном диагнозе 29%. Наряду с типичным гемолитико-уремическим синдромом, тромботической тромбоцитопенической пурпурой, тяжелой преэклампсией и HELLP синдромом аГУС является заболеванием из группы тромботических микроангиопатий (ТМА). В основе аГУС большую роль играют генетические мутации, однако для манифестации заболевания необходима дополнительная сверхмощная стимуляция системы комплемента. У детей таким триггером чаще всего служит инфекция дыхательных путей и желудочно-кишечного тракта, тогда как у взрослых женщин таким мощным, комплемент-активирующим фактором является беременность. Высокая летальность при аГУС обусловлена несколькими причинами: крайне редкой частотой заболевания и, как следствие, низкой информированностью о нем врачей, неспецифичностью симптомов в начале развития аГУС, быстрым развитием полиорганной недостаточности с поражением почек за счет катастрофического генерализованного тромбообразования в микроциркуляторном русле. Успех лечения аГУС во многом зависит от своевременности установления этого диагноза и проведения специфической терапии экулизумабом в сочетании с почечной заместительной терапией при наличии острой почечной недостаточности, интенсивной терапией и быстрым родоразрешением по протоколу ведения тяжелой преэклампсии.</p></abstract><trans-abstract xml:lang="en"><p>Here we present a clinical case of atypical hemolytic uremic syndrome (aHUS) associated with delivery. Even in timely diagnosed patients with aHUS, case fatality rate reaches 29%. Currently, aHUS is considered as a thrombotic microangiopathy, along with typical hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, severe preeclampsia, and HELLP syndrome. There is a considerable genetic predisposition to all abovementioned types of thrombotic microangiopathy; however, additional significant stimulation of the complement system is mandatory for aHUS to occur. In children, it can be triggered by respiratory or gastrointestinal infections, while in women it is typically provoked by pregnancy. High mortality of aHUS is due to its rarity and consequent low awareness, non-specific symptoms at its initiation, and rapid development of multiple organ failure including acute kidney injury due to generalized thrombosis in the microvasculature. Successful treatment of aHUS largely depends on the timeliness of diagnosis, specific therapy with eculizumab in combination with a renal replacement therapy, and rapid delivery according to the protocol on severe pre-eclampsia.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>атипичный гемолитико-уремический синдром</kwd><kwd>тромботическая микроангиопатия</kwd><kwd>ADAMTS-13</kwd><kwd>atypical hemolytic uremic syndrome</kwd><kwd>thrombotic microangiopathy</kwd><kwd>ADAMTS-13</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Nester CM, Thomas CP. Atypical hemolytic uremic syndrome: what is this, how is it diagnosed, and how is it treated? Hematology Am Soc Hematol Educ Program. 2012; 2012: 617-625. doi: 10.1182/asheducation-2012.1.617</mixed-citation><mixed-citation xml:lang="en">Nester CM, Thomas CP. Atypical hemolytic uremic syndrome: what is this, how is it diagnosed, and how is it treated? Hematology Am Soc Hematol Educ Program. 2012; 2012: 617-625. doi: 10.1182/asheducation-2012.1.617</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Meri S. Complement activation in deseases presenting with thrombotic microangiopathy. Eur J Intern Med. 2013; 24 (6): 496-502. doi: 10.1016/j.ejim.2013.05.009</mixed-citation><mixed-citation xml:lang="en">Meri S. Complement activation in deseases presenting with thrombotic microangiopathy. Eur J Intern Med. 2013; 24 (6): 496-502. doi: 10.1016/j.ejim.2013.05.009</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa M, Grinyó JM, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia. 2013; 33 (1): 27-45. doi: 10.3265/Nefrologia.pre2012.Nov.11781</mixed-citation><mixed-citation xml:lang="en">Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa M, Grinyó JM, et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia. 2013; 33 (1): 27-45. doi: 10.3265/Nefrologia.pre2012.Nov.11781</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical haemolytic uraemic syndrome. N Engl J Med. 2013; 368 (23): 2169-2181. doi: 10.1056/NEJMoa1208981</mixed-citation><mixed-citation xml:lang="en">Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical haemolytic uraemic syndrome. N Engl J Med. 2013; 368 (23): 2169-2181. doi: 10.1056/NEJMoa1208981</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
